Vertex Pharmaceuticals gets CHMP opinion recommending Kaftrio label expansion
Vertex Pharmaceuticals (VRTX) announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use adopted an opinion ...
Evercore ISI Remains a Buy on Kiniksa Pharmaceuticals (KNSA)
Evercore ISI analyst Liisa Bayko maintained a Buy rating on Kiniksa Pharmaceuticals (KNSA – Research Report) yesterday and set a price target ...
BioSpace22h
Vertex Severs Liver Gene Therapies Partnership with Verve
The companies were two years into a four-year, $400 million agreement aimed at developing and marketing gene therapies ...
Key Themes, Strategic Moves, and Market Dynamics from JP Morgan's 43rd Annual Healthcare Conference, January 13-16, 2025
The "43rd Annual JP Morgan Healthcare Conference, January 13-16, 2025" report has been added to ResearchAndMarkets.com's offering.The 43rd Annual JP Morgan Healthcare Conference took place in San ...
MarketWatch23h
Sarepta Therapeutics Inc.
Dyne Therapeutics Inc.-4.50% $1.4B ...